|
US4996991A
|
|
Method for following the distribution of particles in neurological or neuromuscular tissue and cells
|
|
US4950221A
|
|
Process for affecting molecules in tissue
|
|
US4923437A
|
|
Process for applying a localized magnetic or electric field
|
|
US4994014A
|
|
Process for treating diseased cells including the step of raising the subjects blood oxygen level
|
|
US5087438A
|
|
Method for affecting intracellular and extracellular electric and magnetic dipoles
|
|
US4829984A
|
|
Method for the improvement of transplantation techniques and for the preservation of tissue
|
|
US4731239A
|
|
Method for enhancing NMR imaging; and diagnostic use
|
|
US4813399A
|
|
Process for the treatment of neurological or neuromuscular diseases and development
|
|
US4889120A
|
|
Method for the connection of biological structures
|
|
US4758429A
|
|
Method for the treatment of arthritis and inflammatory joint diseases
|
|
US4622953A
|
|
Process for the treatment of atherosclerotic lesions
|
|
US4735796A
|
|
Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
|
|
US4622952A
|
|
Cancer treatment method
|
|
US4610241A
|
|
Atherosclerosis treatment method
|
|
US4767611A
|
|
Method for affecting intracellular and extracellular electric and magnetic dipoles
|
|
CA1244082A
|
|
Method for enhancing nmr imaging; and diagnostic use
|
|
US4662359A
|
|
Use of magnetic susceptibility probes in the treatment of cancer
|
|
US4590922A
|
|
Use of ferromagnetic, paramagnetic and diamagnetic particles in the treatment of infectious diseases
|
|
US4569836A
|
|
Cancer treatment by intracellular hyperthermia
|
|
US4531936A
|
|
Device and method for the selective delivery of drugs to the myocardium
|
